| Current Price | $185.25 | Mkt Cap | $8.3B |
|---|---|---|---|
| Open | $184.34 | P/E Ratio | 37.71 |
| Prev. Close | $184.34 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $184.34 - $192.01 | Volume | 1,155,353 |
| 52-Wk Range | $155.02 - $364.31 | Avg. Daily Vol. | 770,046 |
The Company is a provider of medical devices in circulatory support and offer a continuum of care in heart recovery to acute heart failure patients.
| Current Price | $185.25 | Mkt Cap | $8.3B |
|---|---|---|---|
| Open | $184.34 | P/E Ratio | 37.71 |
| Prev. Close | $184.34 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $184.34 - $192.01 | Volume | 1,155,353 |
| 52-Wk Range | $155.02 - $364.31 | Avg. Daily Vol. | 770,046 |
The best Bull and Bear pitches based on recency and number of recommendations.
Despite what appear to be shorter-term headwinds, Abiomed continues to pump out cash and maintain a sterling balance sheet. The valuation is at levels not seen much (if at all) over the past five years. The company's "issues" seem correctable to me,… More
I simply used the screener to identify 1-star companies with the highest 52-week gain. The 1-star rating should mean they are bad companies and the 52-week gain should mean they are overpriced. We’ll see how it works!
Read the most recent pitches from players about ABMD.
Recs
MaestroFool
(86.44)
Submitted: 10/11/2019 1:40:38 AM :
Start Price:
$159.12
NASDAQ:ABMD Score:
+11.55
Abiomed had been crushed this year as sales have suffered following a confusing letter from the FDA, but its heart pumps *are* safe and its tech is revolutionary. I think we'll see great things from the stock from here, the lowest valuation Abiomed has seen in years, though it may take a while. Here's something to help us wait: gross margins at 80%+. Outperform.
Recs
BretterThanMost
(51.17)
Submitted: 9/4/2019 8:46:45 PM :
Start Price:
$185.84
NASDAQ:ABMD Score:
-4.99
Monopoly effect on effective heart procedures; underlying trend of increasing heart issues in the world.
Recs
TMFPencils
(99.86)
Submitted: 8/9/2019 1:48:40 PM :
Start Price:
$191.32
NASDAQ:ABMD Score:
-9.56
Despite what appear to be shorter-term headwinds, Abiomed continues to pump out cash and maintain a sterling balance sheet. The valuation is at levels not seen much (if at all) over the past five years. The company's "issues" seem correctable to me, given its dominant financial position and lack of any meaningful competition. Gonna start this out on CAPS and see how it goes. :-) Outperform.
Find the members with the highest scoring picks in ABMD.
ClaytonHP (< 20) Score: +3,035.29
The Score Leader is the player with the highest score across all their picks in ABMD.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| ClaytonHP | < 20 | 3/27/2009 |
|
3M | $5.42 | +3,317.90% | +282.61% | +3,035.29 | 0 Comment | |
| NoWhereToGoButUp | 76.79 | 3/25/2009 |
|
NS | $5.44 | +3,305.33% | +294.00% | +3,011.33 | 0 Comment | |
| Dennyf10 | 51.96 | 6/3/2009 |
|
1Y | $6.44 | +2,776.55% | +237.55% | +2,539.01 | 0 Comment | |
| TSStechtrader | 35.17 | 8/11/2009 |
|
NS | $7.31 | +2,434.20% | +210.49% | +2,223.71 | 0 Comment | |
| dteasley4 | 86.23 | 6/8/2009 |
|
3Y | $7.30 | +2,437.67% | +234.54% | +2,203.13 | 0 Comment | |
|
henrik1123 | < 20 | 1/8/2010 |
|
5Y | $8.21 | +2,155.54% | +172.11% | +1,983.43 | 0 Comment |
| YahooSIRIous | 81.44 | 7/13/2009 |
|
5Y | $7.93 | +2,236.07% | +253.52% | +1,982.55 | 0 Comment | |
| PitBullCapital | < 20 | 1/11/2010 |
|
5Y | $8.29 | +2,134.62% | +169.99% | +1,964.63 | 0 Comment | |
| QuickStoch | 91.23 | 7/15/2009 |
|
3W | $8.06 | +2,198.39% | +236.65% | +1,961.74 | 0 Comment | |
| ezdoggy | 64.07 | 12/29/2009 |
|
5Y | $8.80 | +2,005.11% | +174.93% | +1,830.18 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
